Home > SS>
Biography

Prof. Vahit Ozmen

Istanbul University, Turkey


Email: vozmen@istanbul.edu.tr


Qualifications


1978 M.D., Istanbul Unıversity, Turkey


Publications (selected)

  1. Avtan L, Avci C, Guvenc H, Igci A, Ozmen V. Laparoscopic myotomy for oesophageal achalasia--adding an antireflux procedure is not always necessary.Int J Clin Pract. 2005 Jan;59(1):35-8.
  2. Asoglu O, Muslumanoglu M, Igci A, Ozmen V, Karanlik H, Ayalp K, Bozfakioglu Y, Kecer M, Parlak M : Breast conserving surgery after primary chemotherapy in locally advanced breast cancer. Acta Chir Belg. 2005 Feb;105(1):62-8.
  3. Asoglu O, Ozmen V, Karanlik H, Tunaci M, Cabioglu N, Igci A, Selcuk UE, Kecer M. Feasibility of surgical management in patients with granulomatous mastitis.Breast J. 2005 Mar-Apr;11(2):108-14.
  4. Ozmen V, Asoglu O, Karanlik H, Unal ES, Yavuz E, Kecer M :  Disseminated necrosis of the breast associated with purpura fulminans. Breast J. 2005 May-Jun;11(3):221-2
  5. Asoglu O, Ozmen V, Karanlik H, Kecer M, Muzlumznoglu M, Igci A, Parlak M. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy. Acta Chir Belg. 2005 May-Jun;105(3):291-6.
  6. Ozmen. Re: Differential Diagnosis of Granulomatous Mastitis. The Breast Journal Vol. 11 Issue 6 Page 536 November 2005
  7. Ozmen V, Karanlik H, Cabioglu N, Igci A, Kecer M, Asoglu O, Tuzlali S, Mudun A. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat. 2006 Jan 95(1);:1-6
  8. Ozmen V, Oran ES, Gorgun E, Asoglu O, Igci A, Kecer M, Dizdaroglu F. Histologic and clinical outcome after laparoscopic Nissen fundoplication for gastroesophageal reflux disease and Barrett's esophagus.Surg Endosc. 2006 Feb;20(2):226-9.
  9. Shyyan R, Masood S, Badwe RA, Errico KM, Liberman L, Ozmen V, Stalsberg H, Vargas H, Vass L; for the Global Summit Diagnosis and Pathology Panel. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J. 2006 Jan-Feb;12 Suppl 1:S27-37.
  10. Ozmen V: Laparoscopic cholecystectomy for gagngrenous cholecytitis in the elderly- Reply. J Laparoendosc Adv Surg Tech A. 16 (1):80-80, 2006.
  11. Sanli Y, Berberoglu K, Turkmen C, Ozmen V, Muslumanoglu M, Igci A, Asoglu O, Kecer M, Tuzlali S, Cantez S, Mudun A. The Value of Combined Peritumoral and Subdermal Injection Techniques for Lymphoscintigraphy in Detection of Sentinel Lymph Node in Breast Cancer.Clin Nucl Med. 2006 Nov;31(11):690-693.
  12. Ozmen V, Cabioglu N. Sentinel lymph node biopsy for breast cancer: Current Controversies. Breast J. 2006 Sep-Oct;12(5 Suppl 2):S134-42. Review.
  13. Ozmen V, Asoglu O, Karanlik H, Cabioglu N, Kecer M, Bakkaloglu H. Primary ovarian cancer presenting with axillary lymph node metastases: a report of two cases. Acta Chir Belg. 2007 Jan-Feb;107(1):75-7.
  14. Ozcinar B, Ozmen V. Superior vena cava syndrome after subclavian vein chemotherapy port replacement in a patient with breast cancer. Breast J. 2007 Jul-Aug;13(4):425-6. PMID: 17593052 [PubMed - in process]
  15. Sen-Oran E, Ozmen V, Bilir A, Cabioglu N, Muslumanoglu M, Igci A, Guney N, Kecer M. Is the thymidine labeling index a good prognostic marker in breast cancer? World J Surg Oncol. 2007 Aug 19;5:93.
  16. Asoglu O, Karanlik H, Muslumanoglu M, Igci A, Emek E, Ozmen V, Kecer M, Parlak M, Kapran Y. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: A single institute experience. Eur J Surg Oncol. 33(10):1199-206, 2007.
  17. Mudun A, Sanli Y, Ozmen V, Turkmen C, Ozel S, Eroglu A, Igci A, Yavuz E, Tuzlali S, Muslumanoglu M, Cantez S. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience.Clin Nucl Med. 2008 Apr;33(4):262-7.
  18. Derin D, Eralp Y, Ozluk Y, Yavuz E, Guney N, Saip P, Igci A, Ozmen V, Kucucuk S, Aslay I, Aydiner A, Topuz E. Lower Level of MAPK Expression is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer. Cancer Invest. 2008 Jun 14:1.
  19. Yip CH, Smith RA, Anderson BO, Miller AB, Thomas DB, Ang ES, Caffarella RS, Corbex M, Kreps GL, McTiernan A, Anyanwu S, Cabioglu N,  Kovtun A,  Murillo R, Myakynkov V, Nyström L, Ozmen V,Remennick L, Russell C, Sener SF, Sepulveda C, Shastri S, Smith RA, Thomas D, Yip CH.; Breast Health Global Initiative Early Detection Panel. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer. 2008 Oct 15;113(8 Suppl):2244-56.
  20. Cabioglu N, Ozmen V, Kaya H, Tuzlali S, Igci A, Muslumanoglu M, Kecer M, Dagoglu T. Increased lymph node positivity in multifocal and multicentric breast cancer. J Am Coll Surg. 2009 Jan;208(1):67-74. Epub 2008 Oct 31.
  21. Ozmen V, Anderson BO. The Challenge of Breast Cancer in Low- and Middle-income Countries—Implementing the Breast Health Global Initiative Guidelines. US Oncology 2008, 76-79.
  22. Asoglu O, Matlim T, Karanlik H, Atar M, Muslumanoglu M, Kapran Y, Igci A, Ozmen V, Kecer M, Parlak M. Impact of laparoscopic surgery on bladder and sexual function after total mesorectal excision for rectal cancer. Surg Endosc. 2009 Feb 23(2):296-303.
  23. Ozmen V, Ozcinar B, Karanlik H, Cabioglu N, Tukenmez M, Disci R, Ozmen T, Igci A, Muslumanoglu M, Kecer M, Soran A. Breast cancer risk factors in Turkish women--a University Hospital based nested case control study. World J Surg Oncol. 2009 Apr 8;7:37.
  24. Gur AS, Unal B, Ozbek U, Ozmen V, Aydogan F, Gokgoz S, Gulluoglu BM, Aksaz E, Ozbas S, Baskan S, Koyuncu A, Soran A; For the Turkish Federation of Breast Disease Associations Protocol MF08-01 investigators. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study. Eur J Surg Oncol 2010 Jan; 36(1):30-5.
  25. Asoglu O, Karanlik H, Parlak M, Kecer M, Muslumanoglu M, Igci A, Ozmen V, Gulluoglu M, Kapran Y. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer. Hepatogastroenterology. 2009 May-Jun;56(91-92): 908-13.
  26. Ozmen V, Unal ES, Muslumanoglu ME, Igci A, Canbay E, Ozcinar B, Mudun A, Tunaci M, Tuzlali S, Kecer M. Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J Surg Oncol. 2010 Jan;36(1):23-9.
  27. Ozcinar B, Muslumanoglu M, Igci A, Gurdal SO, Yavuz E, Kecer M, Dagoglu T, Ozmen V. Clinical importance of micrometastasis in sentinel lymph nodes. Breast. 2010 Sep 20(1):31-3.
  28. Ozmen V, Nilufer Ozaydin A, Cabioglu N, Gulluoglu BM, Unalan PC, Gorpe S, Oner BR, Aribal E, Thomas DB, Anderson BO. 2. Survey on a mammographic screening program in Istanbul, Turkey. Breast J. 2011 May-Jun;17(3):260-7.
  29. Keskin S, Muslumanoglu M, Saip P, Karanlık H, Guveli M, Pehlivan E, Aydoğan F, Eralp Y, Aydıner A, Yavuz E, Ozmen V, Igci A, Topuz E. Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy.Oncology. 2011;81(1):30-8.
  30. Eryilmaz MA, Muslumanoglu M, Ozmen V, Igci A, Koc M. Breast conserving surgery in patients with multifocal/multicentric breast cancer. J BUON. 2011 Jul-Sep;16(3):450-3.